SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT
SIREN : 831200001
Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2017-07-28 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VILLEFRANCHE-DU-PERIGORD (24550), Dordogne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT : revenue, balance sheet and financial ratios
SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VILLEFRANCHE-DU-PERIGORD (24550),
this company of category PME
shows in 2025 a net income positive of 43 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT (SIREN 831200001)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
43 272 €
63 166 €
83 454 €
152 007 €
69 727 €
104 933 €
58 614 €
76 103 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT generates positive net income of 43 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 76 k€ -> 43 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
43 272 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 69%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
69.343%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.188%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
628.997
471.413
290.185
225.694
136.192
112.085
88.445
69.343
Financial autonomy
11.709
15.278
22.075
25.856
37.594
39.165
45.352
49.188
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
69.342025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average
In 2025, the debt ratio of SELURL PHARMACIE DES CHAT... (69.34) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.19%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+6 pts over 3 years
In 2025, the financial autonomy of SELURL PHARMACIE DES CHAT... (49.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 171.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
171.595
Liquidity indicators evolution SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
208.309
209.23
215.718
183.266
278.118
200.926
200.389
171.595
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
171.592025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Average-9 pts over 3 years
In 2025, the liquidity ratio of SELURL PHARMACIE DES CHAT... (171.59) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
Customer payment term (days)
141
0
0
0
0
0
0
0
Supplier payment term (days)
756
0
0
0
0
0
0
0
Positioning of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT is estimated at
687 380 €
(range 466 459€ - 1 078 595€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
466k€687k€1078k€
687 380 €Range: 466 459€ - 1 078 595€
NAF 5 année 2025
Valuation method used
Net Income Multiple
43 272 €
×
15.9x
=687 381 €
Range: 466 460€ - 1 078 595€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT
What is the revenue of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT ?
The revenue of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT is not publicly disclosed (confidential accounts filed with INPI).
Is SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT profitable?
Yes, SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT generated a net profit of 43 k€ in 2025.
Where is the headquarters of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT ?
The headquarters of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT is located in VILLEFRANCHE-DU-PERIGORD (24550), in the department Dordogne.
Where to find the tax return of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT ?
The tax return of SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT operate?
SELURL PHARMACIE DES CHATAIGNIERS AIT KACI LAURENT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart